New Potential Treatment for Celiac Disease in Clinical Study
Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.
Continue ReadingConsider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.
Continue ReadingThe Celiac Disease Foundation uses peer-reviewed research to push our federal government to act responsibly. Our sponsorship of Columbia University’s Biennial Symposium, where the world’s expert celiac researchers share their findings and collaborate on future projects, continues this work.
Continue Reading